Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Management of heart failure in Switzerland

View through CrossRef
AbstractSimilar to other countries, heart failure is a major cause of morbidity and mortality in Switzerland. Among heart failure patients admitted to a Swiss university hospital in 1998, admission therapy included: ACE inhibitors/AT‐II blockers in approximately two‐thirds; diuretics in approximately 70%; and beta‐blockers in approximately one‐third. Easy access to diagnostic tests and limited results of surveys suggest that quality of care of heart failure patients is satisfactory in Switzerland. However, results from ongoing studies are required to assess more reliably the quality of diagnosis and therapy of this high‐risk population in Switzerland.
Title: Management of heart failure in Switzerland
Description:
AbstractSimilar to other countries, heart failure is a major cause of morbidity and mortality in Switzerland.
Among heart failure patients admitted to a Swiss university hospital in 1998, admission therapy included: ACE inhibitors/AT‐II blockers in approximately two‐thirds; diuretics in approximately 70%; and beta‐blockers in approximately one‐third.
Easy access to diagnostic tests and limited results of surveys suggest that quality of care of heart failure patients is satisfactory in Switzerland.
However, results from ongoing studies are required to assess more reliably the quality of diagnosis and therapy of this high‐risk population in Switzerland.

Related Results

Assessing survival time of heart failure patients: using Bayesian approach
Assessing survival time of heart failure patients: using Bayesian approach
AbstractHeart failure is a failure of the heart to pump blood with normal efficiency and a globally growing public health issue with a high death rate all over the world, including...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Undernutrition was a prevalent clinical problem among older adult patients with heart failure in a hospital setting in Northwest Ethiopia
Undernutrition was a prevalent clinical problem among older adult patients with heart failure in a hospital setting in Northwest Ethiopia
BackgroundUndernutrition is a frequently noticed medical problem in patients with heart failure. It is caused by poor nutrient intake, malabsorption, systemic inflammation, neurohu...
Quality improvement in heart failure
Quality improvement in heart failure
Abstract This chapter explores quality improvement in heart failure. Over the last thirty years, much progress has been made in the diagnosis and treatment of heart ...
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
Congenital heart diseases (CHDs) are the structural abnormalities that may occur in the heart, greater veins and arteries or may include the septum between the ventricles and atria...
Clinical predictors of post–liver transplant new-onset heart failure
Clinical predictors of post–liver transplant new-onset heart failure
Objectives of this study were (1) to evaluate preoperative predictors of systolic and diastolic heart failure in patients undergoing liver transplantation (LT) and (2) to describe ...

Back to Top